Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

13F holders, Q3 2025

Institutional positions in Centessa Pharmaceuticals plc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
125
+8 vs. Q2 2025
Shares held
128.3M
+4.76M (+3.9%) vs. Q2 2025
Total value
$3.11B
+$1.49B (+91.7%) vs. Q2 2025
New holders
26
31 more added
Sold out
18
53 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 125 institutions
Q1 2021: 0 institutionsQ2 2021: 50 institutionsQ3 2021: 40 institutionsQ4 2021: 47 institutionsQ1 2022: 44 institutionsQ2 2022: 41 institutionsQ3 2022: 44 institutionsQ4 2022: 44 institutionsQ1 2023: 44 institutionsQ2 2023: 45 institutionsQ3 2023: 49 institutionsQ4 2023: 58 institutionsQ1 2024: 69 institutionsQ2 2024: 80 institutionsQ3 2024: 103 institutionsQ4 2024: 114 institutionsQ1 2025: 130 institutionsQ2 2025: 117 institutionsQ3 2025: 125 institutionsQ4 2025: 147 institutionsQ1 2026: 161 institutionsQ2 2026: 0 institutions
Value heldQ3 2025: $3.11B
Q1 2021: $0Q2 2021: $1.05BQ3 2021: $947.5MQ4 2021: $807.8MQ1 2022: $669.1MQ2 2022: $350.3MQ3 2022: $288.7MQ4 2022: $194.4MQ1 2023: $257.5MQ2 2023: $435.4MQ3 2023: $469.6MQ4 2023: $567.4MQ1 2024: $840.7MQ2 2024: $781.2MQ3 2024: $1.74BQ4 2024: $2.08BQ1 2025: $1.80BQ2 2025: $1.62BQ3 2025: $3.11BQ4 2025: $3.60BQ1 2026: $5.90BQ2 2026: $0
Institutions holding CNTA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 2026161$5.90B
Q4 2025147$3.60B
Q3 2025125$3.11B
Q2 2025117$1.62B
Q1 2025130$1.80B
Q4 2024114$2.08B
Q3 2024103$1.74B
Q2 202480$781.2M
Q1 202469$840.7M
Q4 202358$567.4M
Q3 202349$469.6M
Q2 202345$435.4M
Q1 202344$257.5M
Q4 202244$194.4M
Q3 202244$288.7M
Q2 202241$350.3M
Q1 202244$669.1M
Q4 202147$807.8M
Q3 202140$947.5M
Q2 202150$1.05B
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q2 2025.

Institutions holding CNTA in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Octagon Capital Advisors LP830,000$20.1M3.14%−200,000−19.4%Reduced
Millennium Management LLC902,268$21.9M0.02%−755,619−45.6%Reduced
Point72 Asset Management, L.P.1,072,665$26.0M0.06%−1,518,931−58.6%Reduced
American Century Companies Inc1,096,704$26.6M0.01%−34,004−3.0%Reduced
Affinity Asset Advisors, LLC1,107,162$26.8M2.50%+207,000+23.0%Added
Morgan Stanley1,124,445$27.3M0.00%−669,026−37.3%Reduced
Foresite Capital Management VI LLC1,314,019$31.9M12.31%+60,640+4.8%Added
Federated Hermes, Inc.1,749,650$42.4M0.07%+1,749,650New
Cormorant Asset Management, LP1,925,000$46.7M3.22%−161,600−7.7%Reduced
RTW Investments, LP2,291,747$55.6M0.68%+761,911+49.8%Added
Franklin Resources Inc2,558,414$62.0M0.02%+14,875+0.6%Added
Commodore Capital LP2,850,000$69.1M3.37%−448,289−13.6%Reduced
Perceptive Advisors LLC3,100,902$75.2M2.17%+1,953,967+170.4%Added
TCG Crossover Management, LLC3,136,480$76.1M3.74%+245,664+8.5%Added
Siren, L.L.C.3,227,517$78.3M3.06%−232,512−6.7%Reduced
First Light Asset Management, LLC3,635,816$88.2M8.31%−657,595−15.3%Reduced
Farallon Capital Management, L.L.C.4,331,318$105.0M0.59%−198,000−4.4%Reduced
Price T Rowe Associates Inc4,804,056$116.5M0.01%−1,103,936−18.7%Reduced
Janus Henderson Group PLC5,408,199$131.1M0.06%−1,124,569−17.2%Reduced
FMR LLC6,277,243$152.2M0.01%+2,451,049+64.1%Added
General Atlantic LLC9,681,818$234.8M7.05%00.0%Unchanged
Index Venture Life Associates VI Ltd9,961,789$241.6M100.00%00.0%Unchanged
Adage Capital Partners GP, L.L.C.10,035,000$243.3M0.39%+1,632,000+19.4%Added
Avoro Capital Advisors LLC10,808,080$262.1M3.39%+5,808,080+116.2%Added
Medicxi Ventures Management (Jersey) Ltd19,963,157$484.1M65.03%00.0%Unchanged
Polar Capital Holdings Plc0$00.00%−1,000,000−100.0%Sold out
Deep Track Capital, LP0$00.00%−500,000−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−307,880−100.0%Sold out
Ally Bridge Group (NY) LLC0$00.00%−293,986−100.0%Sold out
Great Point Partners LLC0$00.00%−225,000−100.0%Sold out
Lazard Asset Management LLC0$00.00%−131,351−100.0%Sold out
Bollard Group LLC0$00.00%−100,362−100.0%Sold out
Allostery Investments LP0$00.00%−52,500−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−46,665−100.0%Sold out
State Street Corp0$00.00%−45,912−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−39,379−100.0%Sold out
XTX Topco Ltd0$00.00%−35,898−100.0%Sold out
Rathbone Brothers plc0$00.00%−16,500−100.0%Sold out
OneAscent Financial Services LLC0$00.00%−12,324−100.0%Sold out
Engineers Gate Manager LP0$00.00%−11,356−100.0%Sold out
Quarry LP0$00.00%−8,999−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−1,638−100.0%Sold out
National Bank of Canada0$00.00%−1,600−100.0%Sold out